Crisaborole: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Crisaborole. Educational only — not medical advice.
Labeled uses
EUCRISA is indicated for topical treatment of mild to moderate atopic dermatitis in adult and pediatric patients 3 months of age and older.
Source: FDA labeling via NIH DailyMed (set 609b77de…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.